THE ELITE UNIVERSAL
TEST BANK: KENTUCKY
MPJE (2026/2027
STANDARDS)
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28): Foundational Syntax & Application – Core administrative
definitions, hard-deck retention laws, and foundational board rules.
● Tier 2 (Questions 29–58): Complex Application & Simulation – Advanced scenarios
testing dispensing regulations, telework supervision, and controlled substance workflows.
● Tier 3 (Questions 59–88): Grandmaster Synthesis – High-stakes, multi-variable clinical
and legal problems demanding the seamless integration of overlapping jurisdictional
mandates.
PART I: THE PRIMER
Mastering this specific test bank forges the cognitive architecture required to navigate the
Kentucky Pharmacy Practice Act seamlessly. By internalizing these 88 strategic scenarios, you
eliminate the hesitation that causes fatal errors in both the MPJE and real-world clinical
compliance.
● The Prescriptive Authority Matrix: You cannot dispense what they cannot prescribe.
Mastery of mid-level limits is non-negotiable.
● The "Five-Year" Absolute: Kentucky requires a 5-year retention period for prescription
records and controlled substance inventories, preempting the 2-year federal minimum.
● KASPER Data Supremacy: Reporting is required by the close of the next business day.
Zeroed SSNs are used for animals. Gabapentin is Schedule V.
● The Harm Reduction Pivot: As of recent legislative cycles, syringe logbooks are
abolished (offer Naloxone instead), and PSE annual/package purchase limits are
removed (electronic ID logging remains).
Prescriber Type Schedule II Schedule II Schedule III Limit Benzodiazepine /
Narcotic Limit Non-Narcotic Limit Carisoprodol Limit
APRN 72 hours 72 hours (30 days 30 days 30 days
for
psychostimulants if
psych-certified)
Physician 72 hours 30 days (Includes 30 days 30 days (No
,Prescriber Type Schedule II Schedule II Schedule III Limit Benzodiazepine /
Narcotic Limit Non-Narcotic Limit Carisoprodol Limit
Assistant (PA) hydrocodone Refills)
combos)
Optometrist 72 hours NONE 72 hours 72 hours
(Hydrocodone
combos ONLY)
Podiatrist 3 days (Acute pain Scope dependent 3 days (Acute pain Scope dependent
hydrocodone only) hydrocodone only)
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: An applicant is reviewing the composition of the Kentucky Board of Pharmacy. Based on
KRS 315.150, which conclusion regarding the Board's structure is MOST ACCURATE? A) The
Board consists of seven members appointed by the Governor, all of whom must be pharmacists.
B) The Board consists of eleven members, including a mandatory pharmacy technician
representative. C) The Board consists of six members appointed by the Governor: five licensed
pharmacists and one citizen at large. D) The Board consists of six members elected directly by
the Kentucky Pharmacists Association.
● The Answer: C (The Board consists of six members appointed by the Governor: five
licensed pharmacists and one citizen at large.)
● Distractor Analysis:
○ A is incorrect: The board has six members, not seven.
○ B is incorrect: Senate Bill 95 proposed 11 members, but enacted KRS 315.150
maintains six.
○ D is incorrect: The KPhA nominates candidates, but the Governor appoints them.
The Mentor's Analysis: Regulatory authority rests in a specifically balanced executive body.
When facing board composition questions, the immediate priority is recalling the 5+1 rule.
Professional Intuition: The Board acts as a six-member executive extension of the
Governor to protect the public, not the profession.
Q2: A licensed Kentucky pharmacist is renewing their license for the 2026 period. According to
201 KAR 2:015, which action FIRST fulfills the continuing education (CE) requirements? A)
Completing 15 hours of CE between January 1 and December 31, including one hour of
pharmacy law. B) Completing 30 hours of CE every two years, with no specific subject
requirements. C) Completing 15 hours of CE between March 1 and February 28, including three
hours of live presentation. D) Completing 15 hours of CE between March 1 and February 28,
including one hour related to the opioid epidemic or opioid use disorder.
● The Answer: D (Completing 15 hours of CE between March 1 and February 28, including
one hour related to the opioid epidemic or opioid use disorder.)
● Distractor Analysis:
○ A is incorrect: The CE tracking year is March 1 to February 28.
○ B is incorrect: Kentucky requires annual renewal and CE completion.
○ C is incorrect: Kentucky law does not mandate live CE hours.
The Mentor's Analysis: Licensure maintenance requires strict adherence to administrative
timelines. When verifying CE compliance, the priority is aligning the hours with the March to
February window and the mandated opioid hour. Professional Intuition: Kentucky ties CE to
, the spring renewal cycle, explicitly mandating opioid education through 2028.
Q3: A pharmacist-in-charge (PIC) is terminating their employment at a community pharmacy.
Based on 201 KAR 2:205, what is the IMMEDIATE notification requirement? A) The PIC must
notify the Board of Pharmacy within 30 days of the change. B) The pharmacy permit holder
must notify the DEA within 14 calendar days. C) The PIC must provide written notification to the
Board of Pharmacy within 14 calendar days. D) The PIC must notify KASPER and the Cabinet
for Health and Family Services within 72 hours.
● The Answer: C (The PIC must provide written notification to the Board of Pharmacy within
14 calendar days.)
● Distractor Analysis:
○ A is incorrect: 30 days is the standard for personal address changes, not PIC
changes.
○ B is incorrect: The primary notification is to the state Board, executed by the PIC.
○ D is incorrect: KASPER handles PDMP data, not pharmacy permit tracking.
The Mentor's Analysis: The PIC is the ultimate regulatory anchor for a pharmacy permit. When a
PIC steps down, the priority is officially severing that liability via written notice. Professional
Intuition: Accountability transfers rapidly; the Board must know who holds the keys within
two weeks.
Q4: A Kentucky pharmacy is preparing for a routine DEA and Board inspection. Based on KRS
218A.200, how long must the pharmacy retain its controlled substance inventory records? A)
Two years on-site. B) Three years, with the first year on-site. C) Seven years, per federal
Medicare guidelines. D) Five years, maintained as readily retrievable.
● The Answer: D (Five years, maintained as readily retrievable.)
● Distractor Analysis:
○ A is incorrect: Two years is the federal minimum, but Kentucky is stricter.
○ B is incorrect: Three years applies to certain hard-copy conversions, not the
inventory itself.
○ C is incorrect: Seven years applies to financial/tax records.
The Mentor's Analysis: State law always supersedes federal law when stricter. When
maintaining records, the priority is applying Kentucky's explicit 5-year retention mandate.
Professional Intuition: In Kentucky, if it involves a prescription or controlled substance
record, retain it for five years.
Q5: A patient requests an over-the-counter (OTC) sale of Cheratussin AC
(codeine/guaifenesin). Based on 902 KAR 55:015 and KRS 218A.190, which action is the
MOST ACCURATE legal approach? A) Refuse the sale, as all Schedule V products require a
prescription in Kentucky. B) Dispense up to 240 mL within a 48-hour period, provided the
purchaser is 21 years of age. C) Allow the pharmacy technician to complete the clinical
assessment and ring up the transaction. D) Dispense up to 120 mL to an 18-year-old patient,
ensuring their name is logged in the exempt narcotic registry.
● The Answer: D (Dispense up to 120 mL to an 18-year-old patient, ensuring their name is
logged in the exempt narcotic registry.)
● Distractor Analysis:
○ A is incorrect: Kentucky permits specific OTC Schedule V exempt narcotic sales.
○ B is incorrect: The limit is 120 mL (4 ounces) every 48 hours, and the age is 18.
○ C is incorrect: Only a pharmacist can approve the sale, though an employee may
ring it up.
The Mentor's Analysis: Exempt narcotics require rigid tracking to prevent diversion. When
evaluating OTC Schedule V requests, the priority is verifying the 120 mL/48-hour limit and the
TEST BANK: KENTUCKY
MPJE (2026/2027
STANDARDS)
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28): Foundational Syntax & Application – Core administrative
definitions, hard-deck retention laws, and foundational board rules.
● Tier 2 (Questions 29–58): Complex Application & Simulation – Advanced scenarios
testing dispensing regulations, telework supervision, and controlled substance workflows.
● Tier 3 (Questions 59–88): Grandmaster Synthesis – High-stakes, multi-variable clinical
and legal problems demanding the seamless integration of overlapping jurisdictional
mandates.
PART I: THE PRIMER
Mastering this specific test bank forges the cognitive architecture required to navigate the
Kentucky Pharmacy Practice Act seamlessly. By internalizing these 88 strategic scenarios, you
eliminate the hesitation that causes fatal errors in both the MPJE and real-world clinical
compliance.
● The Prescriptive Authority Matrix: You cannot dispense what they cannot prescribe.
Mastery of mid-level limits is non-negotiable.
● The "Five-Year" Absolute: Kentucky requires a 5-year retention period for prescription
records and controlled substance inventories, preempting the 2-year federal minimum.
● KASPER Data Supremacy: Reporting is required by the close of the next business day.
Zeroed SSNs are used for animals. Gabapentin is Schedule V.
● The Harm Reduction Pivot: As of recent legislative cycles, syringe logbooks are
abolished (offer Naloxone instead), and PSE annual/package purchase limits are
removed (electronic ID logging remains).
Prescriber Type Schedule II Schedule II Schedule III Limit Benzodiazepine /
Narcotic Limit Non-Narcotic Limit Carisoprodol Limit
APRN 72 hours 72 hours (30 days 30 days 30 days
for
psychostimulants if
psych-certified)
Physician 72 hours 30 days (Includes 30 days 30 days (No
,Prescriber Type Schedule II Schedule II Schedule III Limit Benzodiazepine /
Narcotic Limit Non-Narcotic Limit Carisoprodol Limit
Assistant (PA) hydrocodone Refills)
combos)
Optometrist 72 hours NONE 72 hours 72 hours
(Hydrocodone
combos ONLY)
Podiatrist 3 days (Acute pain Scope dependent 3 days (Acute pain Scope dependent
hydrocodone only) hydrocodone only)
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: An applicant is reviewing the composition of the Kentucky Board of Pharmacy. Based on
KRS 315.150, which conclusion regarding the Board's structure is MOST ACCURATE? A) The
Board consists of seven members appointed by the Governor, all of whom must be pharmacists.
B) The Board consists of eleven members, including a mandatory pharmacy technician
representative. C) The Board consists of six members appointed by the Governor: five licensed
pharmacists and one citizen at large. D) The Board consists of six members elected directly by
the Kentucky Pharmacists Association.
● The Answer: C (The Board consists of six members appointed by the Governor: five
licensed pharmacists and one citizen at large.)
● Distractor Analysis:
○ A is incorrect: The board has six members, not seven.
○ B is incorrect: Senate Bill 95 proposed 11 members, but enacted KRS 315.150
maintains six.
○ D is incorrect: The KPhA nominates candidates, but the Governor appoints them.
The Mentor's Analysis: Regulatory authority rests in a specifically balanced executive body.
When facing board composition questions, the immediate priority is recalling the 5+1 rule.
Professional Intuition: The Board acts as a six-member executive extension of the
Governor to protect the public, not the profession.
Q2: A licensed Kentucky pharmacist is renewing their license for the 2026 period. According to
201 KAR 2:015, which action FIRST fulfills the continuing education (CE) requirements? A)
Completing 15 hours of CE between January 1 and December 31, including one hour of
pharmacy law. B) Completing 30 hours of CE every two years, with no specific subject
requirements. C) Completing 15 hours of CE between March 1 and February 28, including three
hours of live presentation. D) Completing 15 hours of CE between March 1 and February 28,
including one hour related to the opioid epidemic or opioid use disorder.
● The Answer: D (Completing 15 hours of CE between March 1 and February 28, including
one hour related to the opioid epidemic or opioid use disorder.)
● Distractor Analysis:
○ A is incorrect: The CE tracking year is March 1 to February 28.
○ B is incorrect: Kentucky requires annual renewal and CE completion.
○ C is incorrect: Kentucky law does not mandate live CE hours.
The Mentor's Analysis: Licensure maintenance requires strict adherence to administrative
timelines. When verifying CE compliance, the priority is aligning the hours with the March to
February window and the mandated opioid hour. Professional Intuition: Kentucky ties CE to
, the spring renewal cycle, explicitly mandating opioid education through 2028.
Q3: A pharmacist-in-charge (PIC) is terminating their employment at a community pharmacy.
Based on 201 KAR 2:205, what is the IMMEDIATE notification requirement? A) The PIC must
notify the Board of Pharmacy within 30 days of the change. B) The pharmacy permit holder
must notify the DEA within 14 calendar days. C) The PIC must provide written notification to the
Board of Pharmacy within 14 calendar days. D) The PIC must notify KASPER and the Cabinet
for Health and Family Services within 72 hours.
● The Answer: C (The PIC must provide written notification to the Board of Pharmacy within
14 calendar days.)
● Distractor Analysis:
○ A is incorrect: 30 days is the standard for personal address changes, not PIC
changes.
○ B is incorrect: The primary notification is to the state Board, executed by the PIC.
○ D is incorrect: KASPER handles PDMP data, not pharmacy permit tracking.
The Mentor's Analysis: The PIC is the ultimate regulatory anchor for a pharmacy permit. When a
PIC steps down, the priority is officially severing that liability via written notice. Professional
Intuition: Accountability transfers rapidly; the Board must know who holds the keys within
two weeks.
Q4: A Kentucky pharmacy is preparing for a routine DEA and Board inspection. Based on KRS
218A.200, how long must the pharmacy retain its controlled substance inventory records? A)
Two years on-site. B) Three years, with the first year on-site. C) Seven years, per federal
Medicare guidelines. D) Five years, maintained as readily retrievable.
● The Answer: D (Five years, maintained as readily retrievable.)
● Distractor Analysis:
○ A is incorrect: Two years is the federal minimum, but Kentucky is stricter.
○ B is incorrect: Three years applies to certain hard-copy conversions, not the
inventory itself.
○ C is incorrect: Seven years applies to financial/tax records.
The Mentor's Analysis: State law always supersedes federal law when stricter. When
maintaining records, the priority is applying Kentucky's explicit 5-year retention mandate.
Professional Intuition: In Kentucky, if it involves a prescription or controlled substance
record, retain it for five years.
Q5: A patient requests an over-the-counter (OTC) sale of Cheratussin AC
(codeine/guaifenesin). Based on 902 KAR 55:015 and KRS 218A.190, which action is the
MOST ACCURATE legal approach? A) Refuse the sale, as all Schedule V products require a
prescription in Kentucky. B) Dispense up to 240 mL within a 48-hour period, provided the
purchaser is 21 years of age. C) Allow the pharmacy technician to complete the clinical
assessment and ring up the transaction. D) Dispense up to 120 mL to an 18-year-old patient,
ensuring their name is logged in the exempt narcotic registry.
● The Answer: D (Dispense up to 120 mL to an 18-year-old patient, ensuring their name is
logged in the exempt narcotic registry.)
● Distractor Analysis:
○ A is incorrect: Kentucky permits specific OTC Schedule V exempt narcotic sales.
○ B is incorrect: The limit is 120 mL (4 ounces) every 48 hours, and the age is 18.
○ C is incorrect: Only a pharmacist can approve the sale, though an employee may
ring it up.
The Mentor's Analysis: Exempt narcotics require rigid tracking to prevent diversion. When
evaluating OTC Schedule V requests, the priority is verifying the 120 mL/48-hour limit and the
